Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor VIII Deficiency”

275 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 275 results

Not applicableStudy completedNCT02581969
What this trial is testing

Extension at 10 Years of the: "Observational Study Evaluating Efficacy and Costs of Secondary Prophylaxis vs On-demand Therapy With Kogenate Bayer in Patients With Severe Haemophilia A."

Who this might be right for
Hemophilia A
Bayer 43
Testing effectiveness (Phase 2)Study completedNCT02576795
What this trial is testing

Gene Therapy Study in Severe Haemophilia A Patients (270-201)

Who this might be right for
Severe Haemophilia A
BioMarin Pharmaceutical 15
Not applicableStudy completedNCT00710619
What this trial is testing

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 52
Not applicableStudy completedNCT04334057
What this trial is testing

Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®

Who this might be right for
Haemophilia A
Novo Nordisk A/S 23
Not applicableEnrolling By InvitationNCT06285071
What this trial is testing

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Who this might be right for
Haemophilia AHaemophilia B
Novo Nordisk A/S 23
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Not applicableStudy completedNCT01000844
What this trial is testing

Joint Outcome Study Continuation for Children With Severe Factor VIII Deficiency

Who this might be right for
Hemophilia
University of Colorado, Denver 11
Large-scale testing (Phase 3)Active Not RecruitingNCT06738485
What this trial is testing

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

Who this might be right for
Congenital Hemophilia A
CSL Behring 60
Large-scale testing (Phase 3)Study completedNCT01480180
What this trial is testing

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 186
Not applicableStudy completedNCT03430154
What this trial is testing

Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)

Who this might be right for
Haemophilia A, Haemophilia B, Obesity
Novo Nordisk A/S 317
Post-approval studies (Phase 4)UnknownNCT03136003
What this trial is testing

DDAVP vs. Exercise in Patients With Mild Hemophilia A

Who this might be right for
Mild Haemophilia A Without Inhibitor
The Hospital for Sick Children 30
Large-scale testing (Phase 3)Ended earlyNCT05695391
What this trial is testing

Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery

Who this might be right for
Hemophilia
Laboratoire français de Fractionnement et de Biotechnologies 2
Not applicableStudy completedNCT01220141
What this trial is testing

Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 51
Large-scale testing (Phase 3)Study completedNCT03528551
What this trial is testing

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 160
Post-approval studies (Phase 4)UnknownNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95
Testing effectiveness (Phase 2)Study completedNCT04204408
What this trial is testing

A Research Study Investigating Mim8 in People With Haemophilia A

Who this might be right for
Healthy VolunteersHaemophilia A With or Without Inhibitors
Novo Nordisk A/S 275
Not applicableStudy completedNCT02253693
What this trial is testing

Exploratory Pilot Study of Physical Activity Monitoring in Adult Patients With Haemophilia A by Means of Accelerometry

Who this might be right for
Hemophilia A, Congenital
University of Valencia 28
Not applicableEnrolling By InvitationNCT06831734
What this trial is testing

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

Who this might be right for
Haemophilia A, Haemophilia B
Novo Nordisk A/S 30
Not applicableStudy completedNCT03034044
What this trial is testing

Post-Marketing Surveillance To Observe Safety And Efficacy Of Xyntha Solofuse Prefilled Syringe

Who this might be right for
Factor VIII Deficiency, CongenitalFactor 8 Deficiency, CongenitalAutosomal Hemophilia A+2 more
Pfizer 106
Not applicableStudy completedNCT03876301
What this trial is testing

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

Who this might be right for
Blood Coagulation DisorderBlood Coagulation Disorders, InheritedCoagulation Protein Disorders+6 more
Spark Therapeutics, Inc. 25
Next Page